{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:55:51Z","timestamp":1788033351523,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NHS"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.breast.2017.07.015","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T01:48:11Z","timestamp":1506736091000},"page":"54-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience"],"prefix":"10.1016","volume":"36","author":[{"given":"Belinda","family":"Kingston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamzeh","family":"Kayhanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narda","family":"Chaabouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Redana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Kalaitzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Parton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Stanway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2068-2593","authenticated-orcid":false,"given":"Alicia","family":"Okines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2017.07.015_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","article-title":"Leptomeningeal carcinomatosis","volume":"25","author":"Grossman","year":"1999","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.breast.2017.07.015_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2298\/VSP120814118M","article-title":"Leptomeningeal carcinomatosis can be presenting manifestation of breast carcinoma","volume":"73","author":"Stojmenovi\u0107","year":"2016","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.breast.2017.07.015_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/1752-1947-8-430","article-title":"Metastatic breast cancer presenting as sequential cranial nerve palsy: a case report","volume":"8","author":"Madgula","year":"2014","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.breast.2017.07.015_bib4","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.5911","article-title":"Leptomeningeal metastasis in breast cancer \u2013 a systematic review","author":"Scott","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.breast.2017.07.015_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11060-014-1361-1","article-title":"CSF CA 15-3 in breast cancer-related leptomeningeal metastases","volume":"117","author":"Le Rhun","year":"2014","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.breast.2017.07.015_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/1097-0142(19830101)51:1<154::AID-CNCR2820510130>3.0.CO;2-K","article-title":"Leptomeningeal carcinomatosis: how does cancer reach the pia-arachnoid?","volume":"51","author":"Kokkoris","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2017.07.015_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejca.2016.10.019","article-title":"External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis","volume":"72","author":"Genre","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2017.07.015_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-2042-y","article-title":"Meningeal carcinomatosis underdiagnosis and overestimation: incidence in a large consecutive and unselected population of breast cancer patients","volume":"15","author":"Mittica","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2017.07.015_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-012-0408-4","article-title":"Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival","volume":"30","author":"Niwi\u0144ska","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.breast.2017.07.015_bib10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10549-011-1682-0","article-title":"Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations","volume":"129","author":"Lee","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.07.015_bib11","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","article-title":"Survival of breast cancer patients with meningeal carcinomatosis","volume":"21","author":"Gauthier","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2017.07.015_bib12","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","article-title":"Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology","volume":"29","author":"Glass","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.breast.2017.07.015_bib13","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of clinical oncology\/college of American Pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.07.015_bib14","unstructured":"Breast cancer incidence (invasive) statistics Read more at http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer\/incidence-invasive#zeGjpTpV77t8HLjR.99. Cancer Research UK; n.d."},{"key":"10.1016\/j.breast.2017.07.015_bib15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.4161\/cbt.10.10.13879","article-title":"Histological, molecular and functional subtypes of breast cancers","volume":"10","author":"Malhotra","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.breast.2017.07.015_bib16","article-title":"Characteristics and outcomes of patients with breast cancer with leptomeningeal metastasis","author":"Morikawa","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2017.07.015_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10549-014-3054-z","article-title":"Leptomeningeal disease and breast cancer: the importance of tumor subtype","volume":"146","author":"Abouharb","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.07.015_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2016.07.014","article-title":"Optimal management of leptomeningeal carcinomatosis in breast cancer patients\u2014a systematic review","author":"Dudani","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2017.07.015_bib19","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","article-title":"The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study","volume":"40","author":"Boogerd","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2017.07.015_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.breast.2015.11.005","article-title":"Sanctuary site leptomeningeal metastases in HER-2 positive breast cancer: a review in the era of trastuzumab","volume":"26","author":"Kordbacheh","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.breast.2017.07.015_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2525-y","article-title":"Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis","volume":"139","author":"Zagouri","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.07.015_bib22","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.30214","volume":"139","author":"Pan","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2017.07.015_bib23","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2017.07.015_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11060-012-0879-3","article-title":"Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors","volume":"109","author":"Segura","year":"2012","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.breast.2017.07.015_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11060-013-1055-0","article-title":"Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases","volume":"112","author":"Kumthekar","year":"2013","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.breast.2017.07.015_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/neuonc\/not305","article-title":"Phase II trial of patupilone in patients with brain metastases from breast cancer","volume":"16","author":"Peereboom","year":"2014","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.breast.2017.07.015_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1290-1","article-title":"A\u00a0pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis","volume":"15","author":"Wu","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2017.07.015_bib28","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.2070","article-title":"Prospective follow-up of a cohort of 112 patients with leptomeningeal metastases of breast cancer recruited from 2007 to 2011: prognostic factors","volume":"30","author":"Zairi","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.07.015_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.breast.2012.10.009","article-title":"Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis","volume":"22","author":"Torrej\u00f3n","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.breast.2017.07.015_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00280-013-2185-y","article-title":"Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience","volume":"72","author":"Jo","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.breast.2017.07.015_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-007-9340-4","article-title":"Breast cancer leptomeningeal metastasis\u2014the role of multimodality treatment","volume":"84","author":"Rudnicka","year":"2007","journal-title":"J\u00a0Neurooncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617305301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617305301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:38:03Z","timestamp":1760776683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977617305301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"alternative-id":["S0960977617305301"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2017.07.015","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2017.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}